MDT

NYSE

Medtronic plc

Latest disclosureSeptember 17, 2026

Insider score Why 0?: 0/ 100
Qualifying buys · 30d: $0

0 purchases · 4 sales

Price by TradingView

Insider transactions 78

Limited filing history

Filters

Last 30 daysNo qualifying insider buying. Sales: $138.88K by 1 insider.

Sale disclosed

Harry Skip Kiil

EVP & President Cardiovascular

Ordinary Shares

Reported value: $138.88K
Reported price: $93.65 / share

Sale disclosed

Matthew R. Walter

SVP, Chief HR Officer

Ordinary Shares

Reported value: $257.93K
Reported price: $83.15 / share

Sale disclosed

Harry Skip Kiil

EVP & President Cardiovascular

Ordinary Shares

Reported value: $318.62K
Reported price: $80.44 / share

Sale disclosed

Harry Skip Kiil

EVP & President Cardiovascular

Ordinary Shares

Reported value: $18.34K
Reported price: $80.45 / share

Reporting insider	Security / transaction	Amount / price	Value	Traded / disclosed	Source
EVP & President Cardiovascular	Ordinary SharesSale	1,483$93.65 / share	$138.88K	Sep 16Filed Sep 17 · 1d later	SEC filing
SVP, Chief HR Officer	Ordinary SharesSale10b5-1	3,102$83.15 / share	$257.93K	Jul 8Filed Jul 9 · 1d later	SEC filing
EVP & President Cardiovascular	Ordinary SharesSale2 trades	4,189avg $80.44 / share	$336.97K	Jun 8Filed Jun 9 · 1d later	2 filings 3,961 @ $80.44 · $318.62KSEC filing 228 @ $80.45 · $18.34KSEC filing

Congress transactions 10

All Congress filings

Sale disclosed

Medtronic plc. Ordinary Shares (MDT) · Stock

The filing reports a sale for a joint account.

Kevin HernReporting House member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: August 24, 2026

Sale disclosed

Medtronic plc. Ordinary Shares (MDT) · Stock

The filing reports a sale for the member.

Richard Dean Dr McCormick official portrait

Richard Dean Dr McCormickReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: July 30, 2026

Partial sale disclosedAmended report

Medtronic plc. Ordinary Shares (MDT) · Stock

The filing reports a partial sale for a joint account.

Julie JohnsonReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: May 7, 2025

Full sale disclosedAmended report

Medtronic plc. Ordinary Shares · Stock

The filing reports a full sale for a joint account.

Thomas H TubervilleReporting Senate member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: August 26, 2024

Purchase disclosed

Medtronic plc. Ordinary Shares · Stock

The filing reports a purchase for the member.

AAAlan ArmstrongReporting Senate member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: March 27, 2026

Partial sale disclosed

Medtronic plc. Ordinary Shares (MDT) · Stock

The filing reports a partial sale for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: May 15, 2026

Sale disclosed

Medtronic plc. Ordinary Shares (MDT) · Stock

The filing reports a sale for a joint account.

Kevin HernReporting House member

Reported amount: $15,001 – $50,000Reported range; exact amount not disclosed.
Trade date: March 20, 2026

Sale disclosed

Medtronic plc. Ordinary Shares (MDT) · Stock

The filing reports a sale for a joint account.

Julie JohnsonReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: December 18, 2025

Partial sale disclosed

Medtronic plc. Ordinary Shares (MDT) · Stock

The filing reports a partial sale for a joint account.

Julie JohnsonReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 13, 2025

Purchase disclosed

Medtronic plc. Ordinary Shares (MDT) · Stock

The filing reports a purchase for the member.

Richard Dean Dr McCormickReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 5, 2025

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0001613103
Latest public acceptance: Sep 17, 2026, 08:17 PM UTC
Score calculated: Oct 8, 2026, 12:08 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.

Reporting insider

Security / transaction

Amount / price

Value

Traded / disclosed

Source

EVP & President Cardiovascular

Ordinary SharesSale

1,483$93.65 / share

$138.88K

Sep 16Filed Sep 17 · 1d later

SEC filing

SVP, Chief HR Officer

Ordinary SharesSale10b5-1

3,102$83.15 / share

$257.93K

Jul 8Filed Jul 9 · 1d later

SEC filing

EVP & President Cardiovascular

Ordinary SharesSale2 trades

4,189avg $80.44 / share

$336.97K

Jun 8Filed Jun 9 · 1d later

2 filings

3,961 @ $80.44 · $318.62KSEC filing
228 @ $80.45 · $18.34KSEC filing

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0001613103
Latest public acceptance: Sep 17, 2026, 08:17 PM UTC
Score calculated: Oct 8, 2026, 12:08 AM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.